Mutations in BARD1 gene may lack the RING domain that interacts with BRCA1, thereby affecting the sub-cellular localization and retention of BRCA1 and compromising tumor suppressor activity; these mechanisms may contribute to carcinogenesis16–18. The gene discussed is BARD1; the disease is neoplasm.